表 3.
PC9、PC9/BB4皮下移植瘤第35天时瘤体重量(g)
Tumor weight evaluated on day 35th according to different treatments
| Cell line | Group | n | Tumor weight (g) | F | P |
| PC9 | Control | 5 | 2.030±0.265 | 63.66 | < 0.000,1 |
| STE029 | 5 | 1.144±0.130 | |||
| Gefitinib | 5 | 0.760±0.221 | |||
| STE029+Gefitinib | 5 | 0.350±0.160 | |||
| PC9/BB4 | Control | 5 | 2.142±0.259 | 26.99 | < 0.000,1 |
| STE029 | 5 | 1.188±0.217 | |||
| Gefitinib | 5 | 1.426±0.378 | |||
| STE029+Gefitinib | 5 | 0.542±0.258 |